<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03007927</url>
  </required_header>
  <id_info>
    <org_study_id>2736</org_study_id>
    <nct_id>NCT03007927</nct_id>
  </id_info>
  <brief_title>Evaluation of Dexamethasone Added to the Usual Infiltration With Bupivacaine in Inguinal Hernia Repair Mesh</brief_title>
  <official_title>Evaluation of Dexamethasone Added to the Usual Infiltration With Bupivacaine in Inguinal Hernia Repair Mesh</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SEBASTIAN ROCHE</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sebasti√°n Roche, MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Santiago Bertone, MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Claudio Brandi, MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Italiano de Buenos Aires</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the impact on the postoperative pain of the dexamethasone addition to the usual
      treatment with bupivacaine in the local infiltration of the surgical area in Inguinal Hernia
      Repair Mesh
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be: controlled, prospective, randomized and double blind.

      Randomized experimental study in which all patients scheduled to undergo unilateral inguinal
      hernia repair and who meet the inclusion criteria and none of the exclusion criteria will be
      invited to participate. At the time of admission to the study, they were assigned randomly to
      one of the two branches of intervention:

      (Group A): infiltration with 0.5% bupivacaine in doses of 1.5 mg / kg body weight diluted in
      physiological solution to a final volume of 30 ml.

      (Group B): infiltration with 0.5% bupivacaine at doses of 1.5 mg / kg body weight +
      dexamethasone 2 ml (8 mg) diluted in physiological solution to a final volume of 30 ml.

      Pain will be evaluated through the visual analogue scale of 0-10 measured at the 1st
      postoperative hour, then every 2 hours until discharge, at discharge, at 8 hours, at 24
      hours, 48 hours and at 8 days .

      It will also evaluate analgesic consumption, complications and labor return
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Actual">June 29, 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain postoperative</measure>
    <time_frame>3 month</time_frame>
    <description>It will be used a 10cm ruler which will allows the patients indicates how much pain they are feeling at the moment, where 0 is no pain at all and 10 is the maximum imaginable pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>take analgesic</measure>
    <time_frame>1 month</time_frame>
    <description>Medication journal completed by patient</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Bupivacaine-Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bupivacaine 1,5 mg/kg + dexamethasone 8 mg 2ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine- physiological solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bupivacaine 1,5 mg/kg + physiological solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine-Dexamethasone</intervention_name>
    <description>Bupivacaine 1,5 mg/kg-Dexamethasone 2ml 8 mg</description>
    <arm_group_label>Bupivacaine-Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine- physiological solution</intervention_name>
    <description>Bupivacaine 1,5 mg/kg- physiological solution</description>
    <arm_group_label>Bupivacaine- physiological solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients older than 18 years.

          2. Unilateral inguinal hernioplasty.

          3. That the surgery is performed in the Ambulatory Surgery Unit (UCA).

        Exclusion Criteria:

          1. Recurrent hernia.

          2. allergies, ongoing infections, diabetes.

          3. Background of rejection of prosthetic material (mesh).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastian SR Roche, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Italiano de Buenos Aires</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Italiano de Buenos Aires, Peron 4190</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aires</city>
        <state>Capital Federal</state>
        <zip>C1199ABB</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2016</study_first_submitted>
  <study_first_submitted_qc>December 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2017</study_first_posted>
  <last_update_submitted>February 20, 2018</last_update_submitted>
  <last_update_submitted_qc>February 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Italiano de Buenos Aires</investigator_affiliation>
    <investigator_full_name>SEBASTIAN ROCHE</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>hernia repair</keyword>
  <keyword>Dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

